Oncology
In oncology, Bayer has a single mission: to develop innovative products that extend and improve the lives of cancer patients. Through our research and strategic alliances, we develop and bring to market therapies aimed at solid tumors, such as advanced renal cell carcinoma, and hematological malignancies, such as chronic lymphocytic leukemia.
At Bayer, passion and purpose combine to produce research and results for people living with cancer.
Our Oncology Products
- Campath® (alemtuzumab)
- Fludara® (fludarabine phosphate)
- Leukine® (sargramostim)
- Nexavar® (sorafenib) tablets*
